Hypoperfusion During Migraine and its Effect on the Retina
DOI:
https://doi.org/10.62480/tjms.2023.vol20.pp129-137Keywords:
RNFL thickness, migraine, symptomsAbstract
One of the most prevalent chronic, complex neurovascular illnesses, migraine, is primarily defined by recurring bouts of incapacitating headaches with aura appearances in up to one-third of patients. Nearly 15% of people get migraines, making it the third most common sickness in the world. Objective: This paper aims to study hypoperfusion during migraines and its Effect on the Retina
References
Stovner L.J., Hagen K., Jensen R., Katsarava Z., Lipton R., Scher A., Steiner T., Zwart J.A. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
Ferroni P., Barbanti P., Della-Morte D., Palmirotta R., Jirillo E., Guadagni F. Redox mechanisms in migraine: Novel therapeutics and dietary interventions. Antioxid. Redox Signal. 2018;28:1144–1183.
Bulboacă A., Dogaru G., Blidaru M., Bulboaca A.C., Stănescu I. Evaluation of oxidative stress in migraine patients with visual aura—the experience of an Rehabilitation Hospital. Balneo Res. J. 2018;9:303–308.
Martin H., Sanchez del Rio M., de Silanes C.L., Alvarez-Linera J., Hernandez J.A., Pareja J.A. Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level-dependent in migraine patients and healthy volunteers: Pathophysiological implications. Headache. 2011;51:1520–1528.
Denuelle M., Boulloche N., Payoux P., Fabre N., Trotter Y., Geraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–218.
Huang J., Zong X., Wilkins A., Jenkins B., Bozoki A., Cao Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia. 2011;31:925–936.
Borkum J.M. Migraine triggers and oxidative stress: A narrative review and synthesis. Headache. 2016;56:12–35.
Förster A., Wenz H., Kerl H.U., Brockmann M.A., Groden C. Perfusion patterns in migraine with aura. Cephalalgia. 2014;34:870–876.
Ekinci M., Ceylan E., Cağatay H.H., Keleş S., Hüseyinoğlu N., Tanyildiz B., Cakici O., Kartal B. Retinal nerve fiber layer, ganglion cell layer and choroid thinning in migraine with aura. BMC Ophthalmol. 2014;14:75.
Reggio E., Chisari C.G., Ferrigno G., Keleş S., Hüseyinoğlu N., Tanyildiz B., Cakici O., Kartal B. Migraine causes retinal and choroidal structural changes: Evaluation with ocular coherence tomography. J. Neurol. 2017;264:494–502.
Sacco S., Ricci S., Carolei A. Migraine and vascular diseases: A review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–795.
Larrosa-Campo D., Ramón-Carbajo C., Para-Prieto M., Calleja-Puerta S., Cernuda-Morollón E., Pascual J. Migraine as a vascular risk factor. Rev. Neurol. 2012;55:349–358.
Bulboacă A.E., Blidaru M., Dogaru G., Bulboacă A., Stănescu I.C. The effect of nitro-oxidative stress on platelet aggregability in migraine patients in a Rehabilitation Hospital—A pilot study. Balneo Res. J. 2018;9:385–389.
Bulboacă A.E., Bolboacă S.D., Stănescu I.C., Sfrângeu C.A., Porfire A., Tefas L., Bulboacă A.C. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int. J. Nanomed. 2018;13:3093–3103.
Lukacs M., Tajti J., Fulop F., Toldi J., Edvinsson L., Vecsei L. Migraine, neurogenic inflammation, drug development—Pharmacochemical aspects. Curr. Med. Chem. 2017;24:3649–3665.
Yücel M., Kotan D., Gurol Çiftçi G., Çiftçi I.H., Cikriklar H.I. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur. Rev. Med. Pharmacol. Sci. 2016;20:930–936.
Aguggia M., Saracco M.G., Cavallini M., Bussone G., Cortelli P. Sensitization and pain. Neurol. Sci. 2013;34:S37–S40. doi: 10.1007/s10072-013-1382-0.
Friedman D.I. The eye and headache. Continuum. 2015;21:1109–1117.
Russo A., Tessitore A., Tedeschi G. Migraine and trigeminal system-I can feel it is coming. Curr. Pain Headache Rep. 2013;17:367.
Shayestagul N.A., Christensen C.E., Amin F.M., Ashina S., Ashina M. Measurement of blood flow velocity in the middle cerebral artery during spontaneous migraine attacks: A systematic review. Headache. 2017;57:852–861.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
